Amyloid blood biomarker detects Alzheimer's disease

Alzheimer's disease (AD) is currently incurable, but there is general agreement that a minimally invasive blood biomarker for screening in preclinical stages would be crucial for future therapy. Diagnostic tools for detection of AD are either invasive like cerebrospinal fluid (CSF) biomarkers o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EMBO Mol Med
Main Authors: Nabers, Andreas, Perna, Laura, Lange, Julia, Mons, Ute, Schartner, Jonas, Güldenhaupt, Jörn, Saum, Kai‐Uwe, Janelidze, Shorena, Holleczek, Bernd, Rujescu, Dan, Hansson, Oskar, Gerwert, Klaus, Brenner, Hermann
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938617/
https://ncbi.nlm.nih.gov/pubmed/29626112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201708763
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados